Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy

Urology

Volumn 61, Issue 3, 2003, Pages 596-600

  Froehner, Michael ^a   Koch, Rainer ^a   Litz, Rainer ^a   Oehlschlaeger, Sven ^a   Noack, Birgit ^a   Manseck, Andreas ^a   Albrecht, D Michael ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CANCER MORTALITY; CARDIOPULMONARY HEMODYNAMICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HAZARD ASSESSMENT; HEART FAILURE; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MATHEMATICAL MODEL; MATHEMATICAL PARAMETERS; MEDICAL ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SURGICAL MORTALITY; THROMBOEMBOLISM;

EID: 0037333592     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02250-1     Document Type: Article

References (23)

1. Yates J.W. Comorbidity considerations in geriatric oncology research. CA Cancer J Clin. 51:2001;329-336.
2. Yancik R., Ganz P.A., Varricchio C.G., et al. Perspectives on comorbidity and cancer in older patients approaches to expand the knowledge base . J Clin Oncol. 19:2001;1147-1151.
3. Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients an Italian Group for Geriatric Oncology study . J Clin Oncol. 20:2002;494-502.
4. Piccirillo J.K. Importance of comorbidity in head and neck cancer. Laryngoscope. 110:2000;593-602.
5. Reid B.C., Alberg A.J., Klassen A.C., et al. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck. 23:2001;985-994.
6. Reid B.C., Alberg A.J., Klassen A.C., et al. Comorbidity and survival of elderly head and neck cancer carcinoma patients. Cancer. 92:2001;2109-2116.
7. Nicolai P., de Zinis L.O.R., Tomenzoli D., et al. Prognostic determinants in supraglottic carcinoma univariate and Cox regression analysis . Head Neck. 19:1997;323-334.
8. Hall S.F., Groome P.A., Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck. 22:2000;317-322.
9. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology. 58:2001;843-848.
10. Graefen M., Karakiewicz P.I., Cagiannos I., et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol. 20:2002;951-956.
11. Albertsen P.C., Fryback D.G., Storer B.E., et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 156:1996;127-132.
12. Fowler J.E., Terrell F.L., Renfroe D.L. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol. 156:1996;1714-1718.
13. Post P.N., Hansen B.E., Kil P.J.M., et al. The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer a population-based study . BJU Int. 87:2001;821-826.
14. Barry M.J., Albertsen P.C., Bagshaw M.A., et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management a retrospective analysis . Cancer. 91:2001;2302-2314.
15. Chijiiwa K., Yamaguchi K., Yamashita H., et al. ASA physical status and age are not factors predicting morbidity, mortality, and survival after pancreatoduodenectomy. Am Surg. 62:1996;701-705.
16. Schulman C.C., Ekane S., Zlotta A.R. Nutrition and prostate cancer evidence or suspicion? Urology. 58:2001;318-334.
17. Neugut A.I., Rosenberg D.J., Ahsan H., et al. Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev. 7:1998;869-873.
18. Catalona W.J., Ramos G.R., Carvalhal G.F. Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin. 49:1999;282-296.
19. Scardino P.T. The Gordon Wilson Lecture natural history and treatment of early stage prostate cancer . Trans Am Clin Climatol Assoc. 111:2000;201-241.
20. Owens W.D., Felts J.A., Spitznagel E.J.L. ASA physical status classifications a study of consistency of ratings . Anesthesiology. 49:1978;239-243.
21. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies development and validation . J Chron Dis. 40:1987;373-383.
22. Kaplan M.H., Feinstein A.R. The importance of classifying initial prognostic comorbidity in longitudinal studies development and validation . J Chron Dis. 27:1974;387-404.
23. Greenfield S., Apolone G., McNeil B.J., et al. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement comorbidity and outcomes after hip replacement . Med Care. 31:1993;141-154.